FDA Inspection
New York Blood Center EnterprisesNew York Blood Center Enterprises – FDA Inspection, Jan 6, 2012
Record Details
This FDA Inspection record concerns New York Blood Center Enterprises, with an inspection on January 6, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 6, 2012
- Product Type
- Biologics
View Company Profile
ID · 62746d58-6cef-4905-b56c-b3276901eeb0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 762262
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Blood Center Enterprises
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 23, 2026 | VAI | New York District Office | Blood and Blood Products |
| December 22, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 6, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 4, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 4, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center Enterprises
- FDA Inspection 1313734 - 2026-04-23
- FDA Inspection 1226373 - 2023-12-22
- FDA Inspection 1110447 - 2019-11-06
- FDA Inspection 1012914 - 2017-05-04
- FDA Inspection 940732 - 2015-09-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.